We’ve had another busy year working with pharmaceutical and biotech company clients to produce high-quality, robust dossiers of evidence to reimbursement authorities in the UK and Ireland.  In the last 12 months alone, we have helped clients submit a total of ten dossiers to NICE, the SMC, the AWMSG and the NCPE, for six different products in oncology, mental health, rare genetic conditions and anti-infectives. In each case, HJCL played a significant role in writing the submission and/or overall project management. We can also support companies on HTA process and training, stakeholder management, HTA communications and lobbying, Patient Access Schemes and appeal hearing preparation.

Tweets

• Working on a diabetes advocacy project that includes CGM access right now. https://t.co/XMHzKgMjAh, Nov 9
• RT @healthywalks: ✅ Spend time in nature ✅ Keep active ✅ Connect with others We all get stressed every now and then, but heading out… https://t.co/wIKI0sFLBm, Nov 7
• RT @MedTechGroup: We’re delighted to announce that Secretary of State for Health and Social Care @MattHancock will address this year’… https://t.co/uJjV3tPHpi, Oct 31
• RT @Agility3Sim: Ever wondered how you can make use of your #BIM data to develop #3D #virtualenvironments? Have a read of our latest… https://t.co/4ScQ2FQFkA, Oct 31
Follow @HJCLTweet